In the current study, the molecular mechanism investigation showed that CBX2 activates the AKT/mTOR signalling pathway by inhibiting the expression of PTEN and affects the carcinogenicity and chemoresistance of glioma cells. This evidence concerns the gene PTEN and glioma.